Steven Brugger Email

CEO, Board Director . BrainChild Bio

Current Roles

Employees:
41
Revenue:
$7.8M
About
We are a kids-first, clinical-stage biotechnology company focused on harnessing the power of CAR-T cell technology for tumors n the central nervous system (CNS), prioritizing pediatrics with plans to expand our technology to adult indications. \n\nWe are building a platform to optimize the application of CAR-T technology in CNS tumors-- prioritizing diffuse intrinsic pontine glioma (DIPG) with plans to expand to other pediatric and adult brain tumors, including brain metastases. \n \n\n \n \n Show more\n \n\n \n\n\n \n \n Show less
BrainChild Bio Address

null, null
United States
BrainChild Bio Email